PNC-27
Price range: $75.00 through $121.00
Become a Member and save 20% on Every Order.
Description
PNC-27 is a synthetic research peptide engineered from a functional domain of the tumor suppressor protein p53, specifically incorporating residues 12–26 associated with MDM2 binding, coupled to a membrane-targeting sequence. In laboratory research settings, PNC-27 is studied for its ability to interact with cancer cell membranes through HDM-2–associated mechanisms, providing a model for investigating selective peptide–membrane interactions in oncology research.
Preclinical studies conducted in vitro have demonstrated that PNC-27 associates preferentially with malignant cell membranes, where it can induce membrane pore formation and destabilization. These properties make PNC-27 a valuable molecular tool for exploring tumor-selective cytolytic mechanisms, apoptotic signaling pathways, and structure–function relationships between peptides and cancer cell membranes under controlled experimental conditions.
PNC-27 is supplied exclusively for scientific and laboratory research use. It is not intended for human or veterinary consumption, clinical investigation, diagnostic use, or therapeutic application.
Chemical Identity & Classification
- Synthetic p53-derived research peptide
- Incorporates p53 residues 12–26 with membrane-targeting domain
- Oncology and peptide–membrane interaction research compound
Why Researchers Study PNC-27
- To investigate p53–MDM2 interaction domains in isolation
- To study cancer cell membrane selectivity in peptide research
- To explore mechanisms of peptide-induced membrane disruption
Key Research Systems & Pathways
- p53–MDM2 (HDM-2) binding interactions
- Cancer cell membrane composition and targeting
- Apoptotic and cytolytic signaling pathways
- Peptide-induced pore formation mechanisms
PNC-27 is synthesized under controlled laboratory conditions to ensure high purity, structural accuracy, and reproducibility for preclinical oncology research.
Mechanism of Action & Pathways
In experimental models, PNC-27 is studied for its interaction with HDM-2 localized at cancer cell membranes, enabling targeted association and membrane destabilization. Research focuses on how this interaction leads to pore formation, altered membrane integrity, and downstream signaling events associated with cell death in malignant cell lines.
Cellular & Molecular Research
PNC-27 is commonly utilized in laboratory studies examining:
- Peptide binding to cancer cell membranes
- Membrane permeability and pore formation assays
- p53-derived peptide structure–function relationships
All investigations are conducted in controlled in vitro or biochemical assay environments.
Oncology & Tumor-Selective Signaling Research
Research applications may include:
- Comparative studies between malignant and non-malignant cell membranes
- Apoptotic and necrotic signaling pathway analysis
- Evaluation of tumor-selective peptide activity in cellular models
These investigations remain exploratory and mechanistic, without therapeutic interpretation.
Experimental Models
- In vitro cancer cell membrane and viability assays
- Ex vivo tumor-derived tissue studies
- Non-clinical in vivo preclinical research models
All use is strictly limited to laboratory research contexts.
What is PNC-27 used for in research?
PNC-27 is used in laboratory research to study peptide–membrane interactions, p53-derived signaling domains, and tumor-selective cytolytic mechanisms in oncology models.
What makes PNC-27 selective for cancer cells in experimental studies?
Selectivity is studied in relation to HDM-2 localization and membrane composition differences observed in malignant cells under experimental conditions.
Which pathways are investigated using PNC-27?
Research focuses on p53–MDM2 interactions, membrane disruption mechanisms, and downstream apoptotic signaling pathways.
Is PNC-27 approved for human or clinical use?
No. PNC-27 is strictly for research use only and is not intended for human consumption, veterinary use, or clinical application.
How should PNC-27 be stored and handled?
PNC-27 should be stored and handled according to standard laboratory peptide storage and handling practices to maintain stability and integrity.
Storage & Handling
All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.
- On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
- Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
- After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.
Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.
Peak Lab Peptides maintains quality-control processes and routinely performs third-party testing to support purity and identity verification. COAs are available upon request for applicable batches. Documentation may vary depending on production timelines.
We aim to make batch-level documentation available whenever possible. Our goal is to expand COA access across the full catalog as production capacity grows.
All products are for laboratory research use only and are not intended for human consumption.
